Peyer's patches are required for oral tolerance to proteins. - Wikidata - wikimedia - TriplyDB

Peyer's patches are required for oral tolerance to proteins.

Peyer's patches are required for oral tolerance to proteins.

http://www.wikidata.org/entity/Q34725322

about

Oral tolerance to food protein IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE)Induction of mucosal tolerance in Peyer's patch-deficient, ligated small bowel loops Functional transforming growth factor-β receptor type II expression by CD4+ T cells in Peyer's patches is essential for oral tolerance induction.A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses.Modulating the intestinal immune system: the role of lymphotoxin and GALT organs.A revisit of mucosal IgA immunity and oral tolerance.CD40L in autoimmunity and mucosally induced tolerance.Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses.Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells Exploiting immune surveillance mechanisms in mucosal vaccine development.Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches.Development of organised conjunctival leucocyte aggregates after corneal transplantation in rats.Effect of probiotic bacteria on induction and maintenance of oral tolerance to beta-lactoglobulin in gnotobiotic mice.Organizing a mucosal defense.The development of the mucosal immune system pre- and post-weaning: balancing regulatory and effector function.Dietary medium-chain triglycerides promote oral allergic sensitization and orally induced anaphylaxis to peanut protein in mice Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora.The importance of regional lymph nodes for mucosal tolerance.The Peyer's patch is a critical immunoregulatory site for mucosal tolerance in experimental autoimmune encephalomylelitis (EAE)A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.Clinical potential of antigen-specific therapies in type 1 diabetes.Food allergy: immune mechanisms, diagnosis and immunotherapy Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis.Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity.Trials in type 1 diabetes: Antigen-specific therapies.Mucosal vaccine delivery: Current state and a pediatric perspective A method for high purity intestinal epithelial cell culture from adult human and murine tissues for the investigation of innate immune function.Effect of a cocoa diet on the small intestine and gut-associated lymphoid tissue composition in an oral sensitization model in rats.Amorphous nanosilica particles block induction of oral tolerance in mice.Peyer's Patches: The Immune Sensors of the Intestine.Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells.Oral administration of type II collagen suppresses pro-inflammatory mediator production by synoviocytes in rats with adjuvant arthritis.Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.Histological Development of the Immune Tissues of a Marsupial, the Red-Tailed Phascogale (Phascogale calura).Reduced frequency of atopic dermatitis in quinoline-allergic patients: the 'hapten-atopy hypothesis'.Reduced allergy rates in atopic eczema to contact allergens used in both skin products and foods: atopy and the 'hapten-atopy hypothesis'.Transcutaneous immunization with pneumococcal surface protein A in mice.

P2860

Q27026259-37A5353C-94E4-4AC9-ACB6-2FA2654FBA1A Q33525565-974B1804-6B4C-4C2B-8B1C-7C43B85B92BC Q33901699-07E8CDE6-42CE-43FB-8CD5-F6C91135840C Q34075716-A8C17B88-8263-431F-B9DA-B19FFCF0D3CA Q34161016-3E61D9DB-56F5-47C7-AA5F-709F5E2964DA Q34298341-C82678E9-B966-4D3F-82A9-42E200E2AA62 Q34419871-BA41B7EE-6761-45D3-B782-2A648A9E1D99 Q34502868-B4FAA7D9-625B-49E2-A82A-082414EE6DBE Q34658459-6C1C3F28-8069-44FC-8758-1F3F1EDDB6B4 Q35134310-0CACB4C1-508E-412B-89E4-2F5CABDAEB47 Q35348677-31D78611-F8A7-430C-A0B5-2D82986F2751 Q35684879-B23036D5-5F02-42BA-B468-A1095ED7121E Q35748193-1AEA4AA3-1F99-4CEA-81A7-A5BFF20F69D1 Q35894672-3A2EC3DC-A446-40E0-8D38-657DAF99E4B7 Q35923434-4FAC4744-322B-4141-940E-610A9299D5E8 Q36209682-9FE52447-C179-4852-BD74-F28577533A31 Q36325095-2B5DFC6B-F6CA-4FCB-9064-1418F58EBAA8 Q36586048-E25C432B-BAAC-4EA9-994E-9F97A5A26855 Q36593729-20273672-448B-40A3-886B-30C948FD6CB9 Q36593742-F0B09071-C23A-49CD-BF89-111264360033 Q36938320-EC2607CC-FDEF-4951-8102-B9BF9AF5D7A5 Q36983731-6FB8F006-5BAE-4908-9E4D-7021EBED8BCB Q37069755-9269AAB5-57A6-45CA-AD06-4A63CFA110D2 Q37088212-2DECC861-B737-4E0F-A464-CFD3AB29473F Q37442005-506DACFE-FE4E-482C-916B-C111DFC27331 Q37583662-616EA1DF-4538-43C7-BD59-515AB37B23FF Q37642857-F52B175D-58B1-4D72-B4F9-B33E6557CDF1 Q38089387-C95C193A-281B-4A8C-8D6B-4B17EF7F1A93 Q38727453-110EA93F-D74B-4F87-B860-D28657F2CEC3 Q38959370-9DFD52A8-62A7-41EF-BB28-7D0303548F04 Q38965462-9EFB2FAE-88FF-40B1-98A0-3FDBF4F20093 Q39844806-ED36451D-7D15-4162-BF20-A0C6F59506BE Q41218623-85E73A71-A53A-4921-9ADD-FA88E9CE7B15 Q42176939-2ED42C39-71C9-46B2-90A9-583E01394EEC Q44461538-677E1EE6-4369-4298-A4FF-AFBB2EC91987 Q44896920-13B9B053-B062-4945-81C7-E4C7C571BD3F Q46634853-136D4B03-9999-436C-8A12-E1542A12EE59 Q46641481-03929BFF-03DA-40A6-A038-286EE6E83C2D Q46750753-F241F356-610E-4A69-82E9-ABA16955C88C Q47309473-9591D262-97E8-4F89-8A00-9886CD0565B6

P2860

Peyer's patches are required for oral tolerance to proteins.

http://www.wikidata.org/entity/Q34725322

description

2001 nî lūn-bûn

@nan

2001 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի մարտին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Peyer's patches are required for oral tolerance to proteins.

@ast

Peyer's patches are required for oral tolerance to proteins.

@en

Peyer's patches are required for oral tolerance to proteins.

@nl

type

label

Peyer's patches are required for oral tolerance to proteins.

@ast

Peyer's patches are required for oral tolerance to proteins.

@en

Peyer's patches are required for oral tolerance to proteins.

@nl

prefLabel

Peyer's patches are required for oral tolerance to proteins.

@ast

Peyer's patches are required for oral tolerance to proteins.

@en

Peyer's patches are required for oral tolerance to proteins.

@nl

P1433

Q34725322-BE73127E-83B5-462B-A43A-27A4230A0335

P1476

Q34725322-FE0D7608-F305-43B0-9FCA-9B722EA9564E

P2093

Q34725322-1421AA8F-9DA7-4C31-8879-9FBB1719A462

Q34725322-558ED1C2-FA79-4127-BB13-262D337D4AA6

Q34725322-A40B13D2-3DCA-4C50-B1A0-4889EC9163A4

Q34725322-B2731DF6-8F8B-47F0-821E-4A47CD82C4C2

Q34725322-B9890252-2697-4382-BF81-DFDA90697122

Q34725322-C782AE48-A6EE-436D-927C-C9DBE50D13C6

Q34725322-D780C236-FBDE-4B2F-B323-43A0AE3403B0

P2860

Q34725322-1B7FFFBE-23E7-4CC3-9779-3E58E568E564

Q34725322-24D55158-31AF-41A9-B12C-1262142D1B7F

Q34725322-2A3CC8FE-F3D3-42FA-9FE2-04A20A1122FA

Q34725322-32DA5B9D-01E8-4F80-904E-B22D2E550E1F

Q34725322-3A789980-E7DA-418A-8B5E-CD67119A8AD2

Q34725322-3B31F065-BD88-41EA-9366-9551E9B54607

Q34725322-3CEF34B5-FABF-4B1E-9D5B-4D85A7525F73

Q34725322-40ABCDDA-2DE3-4C93-8DA5-0594D002E9C7

Q34725322-41DB074D-D44A-462A-8FF5-0A8EE1ED1D70

Q34725322-43B7EC04-0AA1-46E8-9CC7-7F2B8A2F20CD

P304

Q34725322-009D4E86-0470-4CB1-8E2B-0378DC792C60

P31

Q34725322-ED53366C-7DCA-46EC-9591-FF297F6FCB95

P356

Q34725322-ED6BEB95-8111-4727-BFF7-6BDB6BEAF835

P407

Q34725322-9E2A4EAC-9546-4DD6-99F0-5FEE5D445F8F

P433

Q34725322-534FB283-0CB1-45C6-BA8C-31ACE0A470FB

P478

Q34725322-2CE53BC6-06F0-419C-875F-022B2B0F997F

P577

Q34725322-9872AB28-5E79-4F99-98F1-7AC8460B0AE0

P5875

Q34725322-AFCB51D8-25E6-4F94-B22C-3B4FA61B37BF

P698

Q34725322-C0062011-B22D-4594-A56B-7DCBBD799278

P932

Q34725322-7F312C8A-C8C0-4A38-B547-E40F99A587F3

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Peyer's patches are required for oral tolerance to proteins.

@en

P2093

H Kiyono

http://www.w3.org/2001/XMLSchema#string

J R McGhee

http://www.w3.org/2001/XMLSchema#string

K Fujihashi

http://www.w3.org/2001/XMLSchema#string

M Yamamoto

http://www.w3.org/2001/XMLSchema#string

P D Rennert

http://www.w3.org/2001/XMLSchema#string

T Dohi

http://www.w3.org/2001/XMLSchema#string

T Koga

http://www.w3.org/2001/XMLSchema#string

P2860

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin

Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness

Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice

Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice

Oral tolerance in the treatment of inflammatory autoimmune diseases.

Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.

Oral tolerance: new approaches, new problems.

Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut.

Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.

P304

3310-3315

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.061412598

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12084454

http://www.w3.org/2001/XMLSchema#string

P698

11248075

http://www.w3.org/2001/XMLSchema#string

P932

30650

http://www.w3.org/2001/XMLSchema#string